1937

    524518

    KREBSBIO

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    KREBS BIOCHEMICALS & IND Share Price Today

    KREBS BIOCHEMICALS & IND is currently trading at ₹53.6, up by ₹0.62 from the previous close. The stock touched an intraday high of ₹55.60 and a low of ₹51.20 during the latest trading session. Over the past one year, KREBS BIOCHEMICALS & IND has delivered a loss of 36.0%, while the stock has declined 17.29% in the last one month.

    KREBS BIOCHEMICALS & IND performance

    Today’s low Today’s high
    ₹ 51.20 ₹ 55.60
    ₹ 53.69
    52 week low 52 week high
    ₹ 38.33 ₹ 84.35
    ₹ 53.69
    Open Price ₹ 53.50
    Prev. Close ₹ 52.97
    Volume (Shares) 12612.00
    Total traded value ₹ 6.77
    Upper Circuit ₹ 58.26
    Lower Circuit ₹ 47.68
    info

    Investment Returns

    Over 1 Month -17.29% Over 3 Months -13.57% Over 6 Months -15.42% Over 1 Year -36.00%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    KREBS BIOCHEMICALS & IND fundamentals


    • Market cap (Cr) 115.80
    • P/E Ratio (TTM) -6.80
    • Beta 1.14
    • Book Value / share -75.48
    • Return on equity 0.00%
    • EPS (TTM) 0.00
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) -2.34
    info icon alternate text
    • Market cap (Cr) 115.10
    • P/E Ratio (TTM) -6.80
    • Beta 0.83
    • Book Value / share -75.48
    • Return on equity 0.00%
    • EPS (TTM) 0.00
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) -2.34
    info icon alternate text

    KREBS BIOCHEMICALS & IND Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 6.81
    Operating Expense 11.15
    Net Profit -2.34
    Net Profit Margin (%) -34.36
    Earnings Per Share (EPS) -1.09
    EBITDA 1.14
    Effective Tax Rate (%) 0.00
    Particulars DEC 2025 (Values in Cr)
    Revenue 7.27
    Operating Expense 10.39
    Net Profit -3.13
    Net Profit Margin (%) -43.05
    Earnings Per Share (EPS) -1.45
    EBITDA 0.29
    Effective Tax Rate (%) 0.00
    Particulars SEP 2025 (Values in Cr)
    Revenue 4.17
    Operating Expense 10.31
    Net Profit -6.14
    Net Profit Margin (%) -147.24
    Earnings Per Share (EPS) -2.85
    EBITDA -2.79
    Effective Tax Rate (%) 0.00
    Particulars JUN 2025 (Values in Cr)
    Revenue 5.48
    Operating Expense 10.82
    Net Profit -5.32
    Net Profit Margin (%) -97.08
    Earnings Per Share (EPS) -2.47
    EBITDA -2.07
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 6.10
    Operating Expense 14.69
    Net Profit -8.27
    Net Profit Margin (%) -135.57
    Earnings Per Share (EPS) -3.83
    EBITDA -5.06
    Effective Tax Rate (%) -0.24
    Particulars MAR 2026 (Values in Cr)
    Revenue 23.73
    Operating Expense 42.70
    Net Profit -16.93
    Net Profit Margin (%) -71.34
    Earnings Per Share (EPS) -7.85
    EBITDA -3.42
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 43.31
    Operating Expense 70.94
    Net Profit -26.94
    Net Profit Margin (%) -62.20
    Earnings Per Share (EPS) -12.49
    EBITDA -14.32
    Effective Tax Rate (%) -0.07
    Particulars MAR 2024 (Values in Cr)
    Revenue 50.42
    Operating Expense 70.60
    Net Profit -19.73
    Net Profit Margin (%) -39.13
    Earnings Per Share (EPS) -9.16
    EBITDA -8.27
    Effective Tax Rate (%) 0.00
    Particulars MAR 2023 (Values in Cr)
    Revenue 52.13
    Operating Expense 77.44
    Net Profit -24.69
    Net Profit Margin (%) -47.36
    Earnings Per Share (EPS) -11.30
    EBITDA -15.16
    Effective Tax Rate (%) 0.00
    Particulars MAR 2022 (Values in Cr)
    Revenue 59.70
    Operating Expense 105.38
    Net Profit -44.53
    Net Profit Margin (%) -74.58
    Earnings Per Share (EPS) -20.81
    EBITDA -32.84
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share -67.83
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin -33.06
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share -55.29
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 2.83
    EBITDA Margin -16.40
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share -46.13
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.78
    EBITDA Margin -29.08
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share -34.83
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 2.23
    EBITDA Margin -55.01
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share -23.91
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin -31.56
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.14
    Total Assets 169.03
    Total Liabilities 169.03
    Total Equity -146.23
    Share Outstanding 2
    Price to Book Ratio -0.98
    Return on Assets (%) -15.93
    Return on Capital (%) -40.84
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.13
    Total Assets 178.17
    Total Liabilities 178.17
    Total Equity -119.21
    Share Outstanding 2
    Price to Book Ratio -1.10
    Return on Assets (%) -11.07
    Return on Capital (%) -26.58
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.08
    Total Assets 174.98
    Total Liabilities 174.98
    Total Equity -99.46
    Share Outstanding 2
    Price to Book Ratio -1.22
    Return on Assets (%) -14.11
    Return on Capital (%) -29.47
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.10
    Total Assets 189.80
    Total Liabilities 189.80
    Total Equity -75.09
    Share Outstanding 2
    Price to Book Ratio -4.12
    Return on Assets (%) -23.45
    Return on Capital (%) -65.65
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.71
    Total Assets 159.22
    Total Liabilities 159.22
    Total Equity -42.73
    Share Outstanding 1
    Price to Book Ratio -3.72
    Return on Assets (%) -17.81
    Return on Capital (%) -41.82
    Particulars MAR 2025 (Values in Cr)
    Net Income -26.92
    Cash from Operations -7.87
    Cash from Investing -4.96
    Cash from Financing 12.86
    Net change in Cash 0.00
    Free Cash Flow -4.47
    Particulars MAR 2024 (Values in Cr)
    Net Income -19.72
    Cash from Operations 2.36
    Cash from Investing -7.81
    Cash from Financing 5.50
    Net change in Cash 0.05
    Free Cash Flow 11.77
    Particulars MAR 2023 (Values in Cr)
    Net Income -24.69
    Cash from Operations -24.71
    Cash from Investing -12.64
    Cash from Financing 37.34
    Net change in Cash -0.01
    Free Cash Flow -9.55
    Particulars MAR 2022 (Values in Cr)
    Net Income -44.52
    Cash from Operations -17.21
    Cash from Investing -22.89
    Cash from Financing 39.50
    Net change in Cash -0.61
    Free Cash Flow 9.86
    Particulars MAR 2021 (Values in Cr)
    Net Income -28.35
    Cash from Operations -14.57
    Cash from Investing -22.54
    Cash from Financing 37.66
    Net change in Cash 0.53
    Free Cash Flow 3.18
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 30.96 12.85 1.49 237.26 23.12 38.85
    BLISS GVS PHARMA LTD 482.50 38.79 4.28 5117.21 118.35 552.90
    CIPLA LTD 1418.40 30.10 3.32 114584.78 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 431.50 19.03 3.12 1269.95 256.40 480.00
    GLAXOSMITHKLINE PHARMA LT 2455.05 43.22 18.34 41590.03 2088.00 3217.10
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 30.96 21.65 3.98 237.26 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 537.90 24.11 4.20 1555.10 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8025.95 104.82 22.98 20064.88 7630.00 9850.00
    BLISS GVS PHARMA LTD 482.50 52.16 4.42 5117.21 118.35 552.90

    KREBS BIOCHEMICALS & IND shareholding pattern

    Holding
    26.75%
    72.74%
    0.49%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    KREBS BIOCHEMICALS & IND Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    53.69 1.35 redarrow
    red-green-graph indicator
    16 Bearish
    0 Bullish
    • 5 Days 54.30
    • 26 Days 58.60
    • 10 Days 55.70
    • 50 Days 59.70
    • 12 Days 56.20
    • 100 Days 60.40
    • 20 Days 57.90
    • 200 Days 63.60
    53.35 PIVOT
    First Support 51.77 First Resistance 54.56 Second Support 50.56 Second Resistance 56.14 Third Support 48.98 Third Resistance 57.35
    RSI 34.55 ADX 57.44 MACD -2.46 Williams % R -81.28 Commodity Channel Index (CCI) -102.15
    Date 2026-07-17 Week 8412.00 Same Day 9291.00 Month 7577.00
    1 Year 1.14 3 Year 1.08
    Over 1 Month
    -17.29% down
    Over 1 Year
    -36.00% down
    Over 3 Months
    -13.57% down
    Over 3 Years
    -8.95% down
    Over 6 Months
    -15.42% down
    Over 5 Years
    -14.19% down

    KREBS BIOCHEMICALS & IND Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Krebs Biochemicals & Industries Ltd?

    Answer Field

    Krebs Biochemicals & Industries Ltd share price is for NSE ₹ 53.60 & for BSE ₹ 53.38 as on Jul 17 2026 03:27 PM.

    What is the Market Cap of Krebs Biochemicals & Industries Ltd Share?

    Answer Field

    The market cap of Krebs Biochemicals & Industries Ltd for NSE ₹ 115.80 & for BSE ₹ 0.00 as on Jul 17 2026 03:27 PM.

    What is the 52 Week High and Low of Krebs Biochemicals & Industries Ltd?

    Answer Field

    The 52 Week High and Low of Krebs Biochemicals & Industries Ltd for NSE is ₹ 84.35 and ₹ 38.33 and for BSE is ₹ 83.20 and ₹ 38.52.

    What is 1 year return for Krebs Biochemicals & Industries Ltd?

    Answer Field

    The 1 year returns on the stock has been -36.00%.

    What is the P/E Ratio of Krebs Biochemicals & Industries Ltd Share?

    Answer Field

    As on Jul 17 2026 03:27 PM the price-to-earnings (PE) ratio for Krebs Biochemicals & Industries Ltd share is -6.80.

    What is the PB ratio of Krebs Biochemicals & Industries Ltd Share?

    Answer Field

    As on Jul 17 2026 03:27 PM, the price-to-book (PB) ratio for Krebs Biochemicals & Industries Ltd share is -75.48.

    How to Buy Krebs Biochemicals & Industries Ltd Share?

    Answer Field

    You can trade in Krebs Biochemicals & Industries Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Krebs Biochemicals & Industries Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Krebs Biochemicals & Industries Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Krebs Biochemicals & Industries Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |